CannabisNewsBreaks

ThursdayMar 10, 2022 11:21 am

CannabisNewsBreaks – American Cannabis Partners Leveraging Proven Strategies to Position in US Cannabis Industry

American Cannabis Partners (“ACP”) is strengthening its position in the United States’ legal cannabis sector while keeping an eye on federal cannabis reform, which has been a roller coaster ride over the past several years. The introduction of several bills raised hopes for legislative support, especially with a change in the White House seeming to create a more cannabis-friendly atmosphere. But 2021 did not bring the much-anticipated change, and many companies operating in the space, including ACP, are looking for this year to be different. “American Cannabis Partners is eyeing the federal back-and-forth with more interest; federal change could have…

Continue Reading

WednesdayMar 09, 2022 2:21 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in the Driver’s Seat Across One of the Country’s Largest, Fastest-Growing Cannabis Markets

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently announced it had received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company. This acquisition expands RWB’s footprint within the state, having initially only had a single product line in this market – the Platinum Vape(R) brand. Following the acquisition, RWB now controls all aspects of its Michigan operations. “This successful acquisition gives RWB access to 22 owned properties, including nine dispensaries and three cultivation sites in Glendale, Marquette and Au Gres… Going forward, RWB looks to execute its initiatives that include extending its branded product…

Continue Reading

WednesdayMar 09, 2022 12:33 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Positioned to Help Meet Needs of New USDA Initiative

Advanced Container Technologies (OTC: ACTX) today announced it is ideally suited to help meet the needs of the new USDA initiative to build a new and more equitable food system. The “Build Back Better Food System Transformation Initiative” is designed to expand access to nutritious food in rural, tribal and other areas that are currently underserved. ACTX can be an integral part of this effort through providing GrowPods — transportable controlled environment farms. The pods enable cultivation to be moved directly into the areas where food is needed. In addition, locating GrowPods nearer to the point of consumption allows food…

Continue Reading

TuesdayMar 08, 2022 3:06 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Award for Oral Nicotine Compound Patent

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has been granted an Australian patent titled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” The patent expands Lexaria’s world patent portfolio to 24. According to the announcement, the patent expands the company’s international intellectual property rights to apply its proprietary DehydraTECH(TM) enhancement technology to most oral forms of nicotine delivery, which would include pills, tablets, lozenges, capsules, pouches, gums and sprays. In addition to covering different forms of delivery, the patent also includes an array of nicotine forms, such as free base nicotine, nicotine salts, polymer resins of nicotine…

Continue Reading

TuesdayMar 08, 2022 1:32 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that its president and CEO Eric A. Adams will be presenting at the 34th Annual Roth Conference being held March 13-15, 2022. Adams will host a fireside chat with Scoth Henry, managing director and head of pharmaceuticals research at Roth Capital Partners, on Tuesday, March 15. In addition to the live fireside chat, InMed’s virtual Roth Conference presentation is now available on-demand by visiting https://cnw.fm/ardpa. A webcast will be made available to investors following the event in the investor relations section of…

Continue Reading

TuesdayMar 08, 2022 12:22 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number 107475 allows RYAH to market its Smart Medical Inhaler System to medical patients in Canada and potentially represents a significant boost to RYAH’s growth strategy. “The approval from Health Canada recognizing the RYAH Smart Inhaler System as a medical device is a major step towards…

Continue Reading

FridayMar 04, 2022 2:15 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) On Path Toward Improved Margins Through Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a cannabis and CBD product brand builder with a presence in California, Arizona, Oklahoma, Illinois, Michigan, and Florida, most recently celebrated the news that Michigan had granted it adult recreational use prequalification status for manufacture, followed by full licensing to make both medical and adult-use cannabis products in the state. “The company’s lease assignment for a 15,000-square-foot manufacturing and processing facility in the city of Warren led to the launch of operations there [in January], with ‘all necessary equipment already installed and inspections completed’ for medical and adult-use products,” a recent…

Continue Reading

FridayMar 04, 2022 11:08 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes 1st US Import of CBD Products from Colombia

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it has completed its first import of CBD-containing food and beverage products into the United States from Colombia under its Mambe brand. The move comes after Colombian President Ivan Duque signed Resolution 227 last week, providing the necessary framework for the use, distribution and export of cannabis, dried flower and other non-psychoactive derivatives. “We are thrilled to be the first Colombian cannabis operator to capitalize on the law change President Duque signed into effect,” said Flora Growth CEO Luis Merchan. “We are…

Continue Reading

ThursdayMar 03, 2022 3:02 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market

InMed Pharmaceuticals (NASDAQ: INM) is uniquely positioned to leverage the growing worldwide awareness of the potential of cannabinoids and the rising demand for rare cannabinoids. The company has begun this year on a high, following the 2021 acquisition of BayMedica and the launch of cannabicitran (“CBT”) sales. “With the launch of business-to-business sales of CBT in the health and wellness sector, InMed has further expanded its portfolio and its presence in the growing rare cannabinoid market,” reports a recent article. “CBT is the first of several new products InMed is planning to launch in the first half of 2022 in…

Continue Reading

ThursdayMar 03, 2022 2:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Faster, Higher Overall Delivery of Sildenafil into Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released positive results from an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil as potential use in the management of erectile dysfunction. “A clear trend emerged during the course of the study – a faster and higher overall delivery of sildenafil into the bloodstream. During the animal study, it was determined that in as little as four minutes of dosing, the DehydraTECH formulation of sildenafil delivered 74% more of the PDE5 inhibitor into the bloodstream on average than the concentration-matched, generic control formulation. Within seven minutes, the DehydraTECH-sildenafil formulation…

Continue Reading